FindTrial
Sign In

Oral L-Carnitine Improves Outcomes of Patients After Treatment Failure: a Propensity-Matched Study

Oral L-Carnitine Improves Outcomes of Patients After Treatment Failure: a Propensity-Matched Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081145
Enrollment
Unknown
Registered
2024-02-23
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility

Interventions

study group:Oral L-carnitine 3000mg/d until the trigger date for IVF.Take at least 30 days
control group:Not taking any IVF supplements

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 45 Years

Inclusion criteria

Inclusion criteria: From March 2023 to March 2023, patients aged 22-45 who have failed IVF at Weifang People's Hospital and wish to undergo IVF again.

Exclusion criteria

Exclusion criteria: Couples with chromosomal abnormalities, uterine malformations, repeated implantation failures, azoospermic patients

Design outcomes

Primary

MeasureTime frame
Normal fertilization rate;High-quality embryo rate;Oocyte maturation rate;Blastocyst formation rate ;—

Secondary

MeasureTime frame
Clinical pregnancy rate;implantation rate ;—

Countries

China

Contacts

Public ContactZhao Wenjie

Weifang People's Hospital

mahuagang@126.com+86 136 5636 9616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026